Nuclear Medicine & Molecular Imaging Tech — $15K Sign-On

BMC Software; Boston (MA); Sur place; USD 68 000 - 87 000; Plein temps

Avantages offerts par ce poste

Relocation reimbursement

Sign-on bonus

Résumé du poste

BMC Software in Boston seeks a Nuclear Medicine/Molecular Imaging Technologist to handle radiopharmaceuticals, dose calibration, administration and disposal, plus imaging and QC responsibilities.

The role requires a BS or AS in Nuclear Medicine with required certifications, MA license, and NIH protection training; a $15K sign-on bonus and relocation support are offered, with updated pay rates for 2024.

Qualifications

• Requires a Bachelor’s of Science in a scientific field with a certificate in Nuclear Medicine Technology, or an Associate’s degree with 2 years of experience.
• Must be certified upon hire and maintain registrations (NMTCB/ARRT NM and advanced certs).
• Massachusetts Radiologic Technologist license and BLS/CPR required.

Responsabilités

• Procure, prepare, QC, dispense, dose calibrate radiopharmaceuticals and related therapies.
• Administer radiopharmaceuticals and contrast under supervision.
• Perform quality control and operate imaging, lab and computer systems.
• Instruct students and interact with staff to ensure patient care and safety.

Connaissances

Cross-sectional anatomy

Imaging techniques

RIS and NMIS knowledge

Team communication

Time management

Patient care

Formation

Bachelor’s degree in Nuclear Medicine or related science with NM Tech certificate

Associate’s degree in Nuclear Medicine Technology with 2 years experience

Outils

NMIS

RIS

HIS

Description du poste

BMC Software in Boston seeks a Nuclear Medicine/Molecular Imaging Technologist to handle radiopharmaceuticals, dose calibration, administration and disposal, plus imaging and QC responsibilities.

The role requires a BS or AS in Nuclear Medicine with required certifications, MA license, and NIH protection training; a $15K sign-on bonus and relocation support are offered, with updated pay rates for 2024.